Results 21 to 30 of about 27,152 (233)

Uremic Toxins and Cardiovascular System [PDF]

open access: yesCardiology Clinics, 2021
When chronic kidney disease develops, the capacity of the kidneys to clear metabolic waste products from the body is gradually lost. This process results in the retention of a large array of compounds affecting biochemical and biological functions (uremic toxins), of which several can cause cardiovascular damage.
Valkenburg, Sophie   +2 more
openaire   +3 more sources

Food-Derived Uremic Toxins in Chronic Kidney Disease

open access: yesToxins, 2023
Patients with chronic kidney disease (CKD) have a higher cardiovascular risk compared to the average population, and this is partially due to the plasma accumulation of solutes known as uremic toxins.
Mara Lauriola   +4 more
doaj   +1 more source

The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction

open access: yesToxins, 2022
Uremic toxins are a heterogeneous group of molecules that accumulate in the body due to the progression of chronic kidney disease (CKD). These toxins are associated with kidney dysfunction and the development of comorbidities in patients with CKD, being ...
Regiane Stafim da Cunha   +6 more
doaj   +1 more source

Carbamoylated nail proteins as assessed by near-infrared analysis are associated with load of uremic toxins and mortality in hemodialysis patients [PDF]

open access: yes, 2020
Carbamoylation is an important risk factor for accelerated atherogenesis and mortality in patients undergoing hemodialysis (HD). We intended to explore whether carbamoylation as assessed by near-infrared (NIR) analysis of nail proteins is associated with
De Bruyne, Sander   +7 more
core   +1 more source

Lipid Profile Is Negatively Associated with Uremic Toxins in Patients with Kidney Failure—A Tri-National Cohort

open access: yesToxins, 2022
Patients with kidney failure (KF) have a high incidence of cardiovascular (CV) disease, partly driven by insufficient clearance of uremic toxins. Recent investigations have questioned the accepted effects of adverse lipid profile and CV risk in uremic ...
Sam Hobson   +6 more
doaj   +1 more source

Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression

open access: yesToxins, 2018
In chronic kidney disease (CKD), accumulation of uremic toxins is associated with an increased risk of CKD progression. Some uremic toxins result from nutrient processing by gut microbiota, yielding precursors of uremic toxins or uremic toxins themselves,
Esmeralda Castillo-Rodriguez   +13 more
doaj   +1 more source

Binding of bromocresol green and bromocresol purple to albumin in hemodialysis patients [PDF]

open access: yes, 2017
BACKGROUND: Colorimetric albumin assays based on binding to bromocresol purple (BCP) and bromocresol green (BCG) yield different results in chronic kidney disease. Altered dye binding of carbamylated albumin has been suggested as a cause.
Delanghe, Joris   +8 more
core   +1 more source

Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins

open access: yesToxins, 2021
Chronic kidney disease (CKD) is characterized by the retention of solutes named uremic toxins, which strongly associate with high morbidity and mortality. Mounting evidence suggests that targeting uremic toxins and/or their pathways may decrease the risk
Paola Ciceri, Mario Cozzolino
doaj   +1 more source

Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease

open access: yesHeliyon, 2021
One third of the patients with chronic kidney disease (CKD) develop cognitive impairment, which is also an independent risk factor for mortality. However, the concise mechanism of cerebro-renal interaction has not been clarified.
Kimio Watanabe   +6 more
doaj   +1 more source

Changes in the Conformational State of Hemoglobin in Hemodialysed Patients with Chronic Renal Failure [PDF]

open access: yes, 2015
The aim of this study was to evaluate the properties of internal components of erythrocytes in chronic renal failure (CRF) patients undergoing hemodialysis (HD) in comparison to control subjects.
Gwozdzinski, Krzysztof   +1 more
core   +7 more sources

Home - About - Disclaimer - Privacy